Evidence map›Paper›PMID 26023776›Full record

ArticlePloS one2015

Studying Cat (Felis catus) Diabetes: Beware of the Acromegalic Imposter.

Stijn J M Niessen, Yaiza Forcada, Panagiotis Mantis, Christopher R Lamb, Norelene Harrington, Rob Fowkes, Márta Korbonits, Ken Smith, David B Church

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 50 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
50citing papers in PubMed, 1 pooled it
4.2field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

50 citing papers in PubMed, 1 synthesis or guideline pooled it, 75 citations in OpenAlex.

  1. Guideline
  2. Type 2 Diabetes Mellitus in the Northern Tree Shrew (Tupaia belangeri).Journal of the American Association for Laboratory Animal Science : JAALAS · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Hypersomatotropism in diabetic cats in Australia.Journal of feline medicine and surgery · 2025
    Article
  9. Article
  10. SGLT2 inhibitor use in the management of feline diabetes mellitus.Journal of veterinary pharmacology and therapeutics · 2025
    Review
  11. Article
  12. Feline Comorbidities: Hypersomatotropism-induced diabetes in cats.Journal of feline medicine and surgery · 2024
    Review
  13. Article
  14. Pets, Genuine Tools of Environmental Pollutant Detection.Animals : an open access journal from MDPI · 2023
    Review
  15. Article
  16. Article
  17. Survival, remission, and quality of life in diabetic cats.Journal of veterinary internal medicine · 2023
    Article
  18. Article
  19. Therapy for feline secondary hypertriglyceridemia with fenofibrate.Journal of feline medicine and surgery · 2022
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Stijn J M NiessenDepartment of Clinical Science and Services, Royal Veterinary College, University of London, London, United Kingdom; The Diabetes Research Group, Institute of Cellular Medicine, University of Newcastle, Newcastle, Tyne and Wear, United Kingdom.
Yaiza ForcadaDepartment of Clinical Science and Services, Royal Veterinary College, University of London, London, United Kingdom.
Panagiotis MantisDepartment of Clinical Science and Services, Royal Veterinary College, University of London, London, United Kingdom.
Christopher R LambDepartment of Clinical Science and Services, Royal Veterinary College, University of London, London, United Kingdom.
Norelene HarringtonDepartment of Pathology and Pathogen Biology, Royal Veterinary College, University of London, London, United Kingdom.
Rob FowkesDepartment of Comparative Biology, Royal Veterinary College, University of London, London, United Kingdom.
Márta KorbonitsDepartment of Endocrinology, Barts & the Royal London School of Medicine & Dentistry, WHRI, Queen Mary University of London, London, United Kingdom.
Ken SmithDepartment of Pathology and Pathogen Biology, Royal Veterinary College, University of London, London, United Kingdom.
David B ChurchDepartment of Clinical Science and Services, Royal Veterinary College, University of London, London, United Kingdom.
Royal Veterinary College · GBUniversity of London · GBQueen Mary University of London · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Naturally occurring diabetes mellitus (DM) is common in domestic cats (Felis catus). It has been proposed as a model for human Type 2 DM given many shared features. Small case studies demonstrate feline DM also occurs as a result of insulin resistance due to a somatotrophinoma. The current study estimates the prevalence of hypersomatotropism or acromegaly in the largest cohort of diabetic cats to date, evaluates clinical presentation and ease of recognition. Diabetic cats were screened for hypersomatotropism using serum total insulin-like growth factor-1 (IGF-1; radioimmunoassay), followed by further evaluation of a subset of cases with suggestive IGF-1 (>1000 ng/ml) through pituitary imaging and/ or histopathology. Clinicians indicated pre-test suspicion for hypersomatotropism. In total 1221 diabetic cats were screened; 319 (26.1%) demonstrated a serum IGF-1>1000 ng/ml (95% confidence interval: 23.6-28.6%). Of these cats a subset of 63 (20%) underwent pituitary imaging and 56/63 (89%) had a pituitary tumour on computed tomography; an additional three on magnetic resonance imaging and one on necropsy. These data suggest a positive predictive value of serum IGF-1 for hypersomatotropism of 95% (95% confidence interval: 90-100%), thus suggesting the overall hypersomatotropism prevalence among UK diabetic cats to be 24.8% (95% confidence interval: 21.2-28.6%). Only 24% of clinicians indicated a strong pre-test suspicion; most hypersomatotropism cats did not display typical phenotypical acromegaly signs. The current data suggest hypersomatotropism screening should be considered when studying diabetic cats and opportunities exist for comparative acromegaly research, especially in light of the many detected communalities with the human disease.

Indexed as

AcromegalyDiabetes Mellitus, Type 2AnimalsCat DiseasesCatsHumansInsulin-Like Growth Factor IRadiographyInsulin-Like Growth Factor I

Identifiers

PMID26023776
PMCPMC4449218
OpenAlexW1523183829

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.